Preadipocyte response and impairment of differentiation in an inflammatory environment

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 662-667

  Poulain Godefroy, Odile ^a   Froguel, Philippe ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

3T3 L1; Adipocyte; Adipokine; Differentiation; Inflammation; Obesity; TLR4

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; EOTAXIN; FATTY ACID BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LEPTIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN SYNTHASE; RANTES; RESISTIN; TOLL LIKE RECEPTOR 4; VISFATIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; RAT; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CHEMOKINES; CYCLOOXYGENASE 2; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; NITRIC OXIDE SYNTHASE TYPE II; TOLL-LIKE RECEPTOR 4;

EID: 33947637709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.053     Document Type: Article

References (36)

1. Trayhurn P., and Wood I. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92 (2004) 347-355
2. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25 (2004) 4-7
3. Medzhitov R., and Janeway C.J. The Toll receptor family and microbial recognition. Trends Microbiol. 8 (2000) 452-456
4. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit. Care Med. 29 (2001) S16-S18
5. Lee J., Sohn K., Rhee S., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001) 16683-16689
6. Rifkin I., Leadbetter E., Busconi L., Viglianti G., and Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204 (2005) 27-42
7. Shi H., Kokoeva M., Inouye K., Tzameli I., Yin H., and Flier J. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006) 3015-3025
8. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L., and Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 278 (2003) 9850-9855
9. Hwa Cho H., Bae Y., and Jung J. Role of toll-like receptors on human adipose-derived stromal cells. Stem. Cells 24 (2006) 2744-2752
10. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I.R., and Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109 (2007) 1422-1432
11. Gregoire F., Smas C., and Sul H. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
12. Thompson G., Trainor D., Biswas C., LaCerte C., Berger J., and Kelly L. A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells. Anal. Biochem. 330 (2004) 21-28
13. Lin Y., Lee H., Berg A., Lisanti M., Shapiro L., and Scherer P. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275 (2000) 24255-24263
14. Weinberg J. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunol. Res. 22 (2000) 319-341
15. Wang Y., Kim K., Kim J., and Sul H. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J. Nutr. 136 (2006) 2953-2956
16. Petruschke T., Röhrig K., and Hauner H. Transforming growth factor beta (TGF-β) inhibits the differentiation of human adipocyte precursor cells in primary culture. Int. J. Obes. (Lond.) 18 (1994) 532-536
17. Wellen K., and Hotamisligil G. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112 (2003) 1785-1788
18. Xu H., Barnes G., Yang Q., Tan G., Yang D., Chou C., Sole J., Nichols A., Ross J., Tartaglia L., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
19. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr. Diab. Rep. 6 (2006) 177-181
20. Lee J., Zhao L., Youn H., Weatherill A., Tapping R., Feng L., Lee W., Fitzgerald K., and Hwang D. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279 (2004) 16971-16979
21. Dehus O., Hartung T., and Hermann C. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay. J. Endotoxin. Res. 12 (2006) 171-180
22. Cottam D., Mattar S., Barinas-Mitchell E., Eid G., Kuller L., Kelley D., and Schauer P. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes. Surg. 14 (2004) 589-600
23. Christiansen T., Richelsen B., and Bruun J. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond.) 29 (2005) 146-150
24. Vasudevan A., Wu H., Xydakis A., Jones P., Smith E., Sweeney J., Corry D., and Ballantyne C. Eotaxin and obesity. J. Clin. Endocrinol. Metab. 91 (2006) 256-261
25. Herder C., Haastert B., Muller-Scholze S., Koenig W., Thorand B., Holle R., Wichmann H., Scherbaum W., Martin S., and Kolb H. Association of Systemic Chemokine Concentrations With Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54 (2005) S11-S17
26. Weiss S. Obesity: insight into the origins of asthma. Nat. Immunol. 6 (2005) 537-539
27. Teran L. CCL chemokines and asthma. Immunol. Today 21 (2000) 235-242
28. Engeli S., Janke J., Gorzelniak K., Bohnke J., Ghose N., Lindschau C., Luft F., and Sharma A. Regulation of the nitric oxide system in human adipose tissue. J. Lipid. Res. 45 (2004) 1640-1648
29. Gaudiot N., Ribiere C., Jaubert A., and Giudicelli Y. Endogenous nitric oxide is implicated in the regulation of lipolysis through antioxidant-related effect. Am. J. Physiol. Cell Physiol. 279 (2000) C1603-C1610
30. Xie Y., Kang X., Ackerman W.t., Belury M., Koster C., Rovin B., Landon M., and Kniss D. Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes. Obes. Metab. 8 (2006) 83-93
31. Marx N., Duez H., Fruchart J., and Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94 (2004) 1168-1178
32. Song M., Kim K., Yoon J., and Kim J. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 346 (2006) 739-745
33. Fain J., Bahouth S., and Madan A. TNFalpha release by the nonfat cells of human adipose tissue. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 616-622
34. Krutzik S., Tan B., Li H., Ochoa M., Liu P., Sharfstein S., Graeber T., Sieling P., Liu Y., Rea T., Bloom B., and Modlin R. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11 (2005) 653-660
35. Nagai Y., Garrett K., Ohta S., Bahrun U., Kouro T., Akira S., Takatsu K., and Kincade P. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24 (2006) 801-812
36. Farmer S. Transcriptional control of adipocyte formation. Cell Metab. 4 (2006) 263-273